Stablon and inflammation Patient Reports February 09, 2012

Stablon Side Effects Report #5706715-7
Stablon side effect was reported by a Consumer or non-health professional from FRANCE on Apr 11, 2008. Male patient, 81 years of age, was treated with Stablon. After drug was administered, patient experienced the following side effects: bradycardia, c-reactive protein increased, cardiac hypertrophy, fluid replacement, hyponatraemia, hypotonia, inflammation, left atrial dilatation, loss of consciousness. Stablon dosage: 12.5 MG, QD. During the same period patient was treated with ATACAND, MODOPAR, TRIATEC, XATRAL, HEMIGOXINE NATIVELLE, MINISINTROM, LEPONEX. Patient was hospitalized. Patient recovered.